Posts

Egyptian Drug Authority approves Lilly and EVA’s insuli...

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authorit...

Novo Nordisk invests $1.2bn in new Denmark facility

Construction has already begun on the Ozempic-producer’s new Denmark production ...

Novo Holdings completes Catalent acquisition for $16.5bn

Novo Holdings has completed the previously announced acquisition of Catalent in ...

Pharma’s data and analytics market forecast to reach to...

A new report identifies data content management as the primary driver of growth ...

The healthcare sector must change its industrial refrig...

Industrial refrigeration is key to the healthcare industry, but it contributes m...

Abera and Orexo partner for vaccine powder formulations

Abera and Orexo have entered a partnership to develop and test the powder formul...

Corcept’s ALS Modulator Fails to Meet Primary Endpoint ...

After Amylyx and PTC, Corcept has also decided to withdraw from the amyotrophic ...

FDA Identifies Further Safety Concerns With Intercept’s...

The Food and Drug Administration (FDA) has uncovered additional safety concerns ...

Ro Partners With Eli Lilly to Offer Zepbound, a Weight-...

Ro, a direct-to-consumer health and wellness company, has announced a partnershi...

Small cell lung cancer: Navigating the global clinical ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’...

EMA recommends expanding approval of Ofev to children a...

Boehringer Ingelheim’s blockbuster Ofev could be set for an expanded indication ...

Denmark’s HTA evolution

New HTA statistics produced by Denmark’s Medicinrådet for 2024 have prompted Glo...

Bavarian Nordic signs mpox vax deal with Serum Institut...

Bavarian Nordic has signed a licence and manufacturing agreement with the Serum ...

GSK’s lung cancer therapy gains EMA PRIME designation

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for...